Instadose Pharma Corp Stock Technical Analysis

INSD Stock  USD 0  0.00  0.00%   
Instadose Pharma technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Instadose Pharma Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Instadose, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Instadose
  
Instadose Pharma's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Instadose Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Instadose Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Instadose Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Instadose Pharma Corp Technical Analysis

Indicator
Time Period
Execute Indicator
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twenty-eight with a total number of output elements of thirty-three. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Instadose Pharma Corp volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Instadose Pharma Corp Trend Analysis

Use this graph to draw trend lines for Instadose Pharma Corp. You can use it to identify possible trend reversals for Instadose Pharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Instadose Pharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Instadose Pharma Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Instadose Pharma Corp applied against its price change over selected period. The best fit line has a slop of   0.00  , . It has 122 observation points and a regression sum of squares at 0.0, which is the sum of squared deviations for the predicted Instadose Pharma price change compared to its average price change.

About Instadose Pharma Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Instadose Pharma Corp on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Instadose Pharma Corp based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Instadose Pharma Corp price pattern first instead of the macroeconomic environment surrounding Instadose Pharma Corp. By analyzing Instadose Pharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Instadose Pharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Instadose Pharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2010 2023 2024 (projected)
Interest Debt Per Share0.0015250.0013730.00122
Revenue Per Share4.8E-54.3E-53.8E-5

Complementary Tools for Instadose Stock analysis

When running Instadose Pharma's price analysis, check to measure Instadose Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Instadose Pharma is operating at the current time. Most of Instadose Pharma's value examination focuses on studying past and present price action to predict the probability of Instadose Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Instadose Pharma's price. Additionally, you may evaluate how the addition of Instadose Pharma to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance